Metabolize has raised $3.2M in seed funding, a round backed by Christina Ulardic, Maia Ventures, LongGame Ventures, and SOSV.
The company is building consumer products for metabolic health, rooted in research that originated at Stanford Medicine. Its approach, which it calls Precision Metabolite™ Technology, is designed to work with the body’s natural biology rather than override it-a positioning that sets it apart from traditional supplementation. The fresh capital arrives as interest in metabolic health continues to broaden beyond clinical settings into everyday consumer goods.
